Sector
PharmaceuticalsOpen
₹350.5Prev. Close
₹344.85Turnover(Lac.)
₹26.19Day's High
₹368.95Day's Low
₹347.252 Week's High
₹64652 Week's Low
₹302.05Book Value
₹232.38Face Value
₹10Mkt Cap (₹ Cr.)
111.55P/E
15.68EPS
23.02Divi. Yield
0.2830 May 2024
12:00 AM
AGM
Announcement Date: 30 May, 2024
26 Mar 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 61.91 | 60.05 | 43.73 | 26.55 |
Net Worth | 65 | 63.14 | 46.82 | 29.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 179.01 | 137.45 | 111.13 | 92.52 |
yoy growth (%) | 30.23 | 23.67 | 20.12 | 30.19 |
Raw materials | -164.24 | -125.61 | -102.62 | -81.92 |
As % of sales | 91.74 | 91.38 | 92.33 | 88.54 |
Employee costs | -1.49 | -1.44 | -1.38 | -1.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.36 | 5.79 | 2.15 | 4.92 |
Depreciation | -0.49 | -0.42 | -0.41 | -0.41 |
Tax paid | -2.01 | -1.54 | -0.62 | -1.7 |
Working capital | 3.61 | 5.53 | -1.22 | 5.89 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 30.23 | 23.67 | 20.12 | 30.19 |
Op profit growth | 30.75 | 108.66 | -46.6 | 61.6 |
EBIT growth | 27.49 | 110.67 | -44.39 | 69.61 |
Net profit growth | 25.87 | 175.9 | -52.26 | 83.35 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Lalit Mehta
Director & CFO
Rajesh Mehta
Independent Director
Renu P Dharod
Executive Director
Megh Mehta
Company Sec. & Compli. Officer
Nishant Kankaria
Plot No A2/3445,
GIDC Phase IV,
Gujarat - 393002
Tel: 91-2646-220774
Website: http://www.samratpharmachem.com
Email: [email protected]
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Summary
Samrat Pharmachem Limited was incorporated on June 16, 1992. The Companys principal activities are manufacturing and selling chemicals.The Company floated a new 100% subsidiary company during the year...
Read More
Reports by Samrat Pharmachem Ltd
What is the Samrat Pharmachem Ltd share price today?
What is the Market Cap of Samrat Pharmachem Ltd?
What is the PE and PB ratio of Samrat Pharmachem Ltd?
What is the 52 Week High and Low of Samrat Pharmachem Ltd?
What is the CAGR of Samrat Pharmachem Ltd?
What is the shareholding pattern of Samrat Pharmachem Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.